Working… Menu
Trial record 78 of 226 for:    Intestinal | maltodextrin

Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01265355
Recruitment Status : Completed
First Posted : December 23, 2010
Last Update Posted : February 4, 2015
Karolinska Institutet
Information provided by (Responsible Party):
Christian Medical College, Vellore, India

Brief Summary:
Rotavirus is the commonest cause of severe gastroenteritis in young children worldwide. The investigators hypothesize that use of a food based prophylactic will decrease incidence of rotavirus infection in young children in south India, prevent intestinal damage and overall result in lower infection rates and better gut function. This trial will evaluate the efficacy of prevention of rotavirus gastroenteritis when an anti-rotavirus protein or antibody fragments expressed in yeast or placebo are given daily as a food supplement to children between the ages of 6 and 12 months. The children will followed for one year and rates of rotavirus diarrhoea, antibody responses and gut function will be compared between children receiving antibody fragments or placebo.

Condition or disease Intervention/treatment Phase
Rotavirus Gastroenteritis Dietary Supplement: Anti-rotavirus protein Dietary Supplement: Maltodextrin Phase 2 Phase 3

Detailed Description:
The study will be carried out in an urban slum area in Vellore, south India. Children between the ages of 6 and 12 months will be recruited for participation in the study. They will be randomized to receive supplementation with ARP or placebo, and will be followed for a period of one year, with weekly home visits and monitoring of all episodes of diarrhoea. In addition, every two weeks, surveillance stool samples will be collected and tested for rotavirus to identify asymptomatic infections by PCR. All episodes of diarrhoea will be investigated intensively for bacterial, viral and parasitic agents of diarrhoea using both conventional and molecular techniques and all cases will be treated appropriately at the study clinic or referral hospital as required. Monthly anthropometric measurements will be carried out to estimate rates of growth and to identify growth faltering. Blood samples will be taken at 4, 8 and 12 months for estimation of anti-rotavirus IgA and IgG antibodies. Studies on intestinal absorption and permeability will be carried out at recruitment, 6 and 12 months by the lactulose:mannitol test (measured by HPLC detection of sugars). All rotavirus strains obtained will be characterized by genotyping.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 330 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Community Based Prophylaxis for Rotavirus Gastroenteritis in Children by an Anti-rotavirus Protein Based Food Supplement
Study Start Date : March 2011
Actual Primary Completion Date : June 2012
Actual Study Completion Date : June 2012

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Anti-rotavirus protein Dietary Supplement: Anti-rotavirus protein
11mg ARP In 1 Gm Product Daily For 12 Months, given in orange juice

Placebo Comparator: Maltodextrin Dietary Supplement: Maltodextrin
Maltodextrin 1 gm daily

Primary Outcome Measures :
  1. Incidence of rotavirus gastroenteritis [ Time Frame: One year after recruitment ]

Secondary Outcome Measures :
  1. IgA And IgG Antibody Response To Rotavirus [ Time Frame: At 4, 8 And 12 Months after recruitment ]
  2. Weight For Height Z Score [ Time Frame: At 6 and 12 months after recruitment ]
  3. Intestinal Function by lactulose:mannitol [ Time Frame: at 3, 6, 9 and 12 months ]
  4. Characterization of strains causing rotavirus gastroenteritis [ Time Frame: Over 12 months ]
  5. Incidence of adverse events [ Time Frame: Over 12 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   6 Months to 12 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy child aged 6 to 12 months, families resident in the study area, willing to participate and available for follow up for a period of one year
  • Normal birth weight (> 2.5 kg), child exclusively breast fed for at least four months

Exclusion Criteria:

  • Families not available for a follow up period of one year
  • Children with any atopic conditions
  • Children with gross congenital anomalies including cardiovascular, renal or hepatic disease
  • Children with syndromic or serological evidence of HIV infection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01265355

Layout table for location information
Christian Medical College
Vellore, TN, India, 632004
Sponsors and Collaborators
Christian Medical College, Vellore, India
Karolinska Institutet
Layout table for investigator information
Principal Investigator: Gagandeep Kang, MD Christian Medical College, Vellore, India
Study Director: Uma Raman, MDS Christian Medical College, Vellore, India

Layout table for additonal information
Responsible Party: Christian Medical College, Vellore, India Identifier: NCT01265355     History of Changes
Other Study ID Numbers: CMCLB001
First Posted: December 23, 2010    Key Record Dates
Last Update Posted: February 4, 2015
Last Verified: February 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Gastrointestinal Diseases
Digestive System Diseases